SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-030137
Filing Date
2023-08-21
Accepted
2023-08-21 16:48:46
Documents
13
Period of Report
2023-08-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ocgn-20230821.htm   iXBRL 8-K 29069
2 EX-99.1 ocgn-20230821xex991.htm EX-99.1 75108
  Complete submission text file 0001628280-23-030137.txt   238257

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ocgn-20230821.xsd EX-101.SCH 1898
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ocgn-20230821_lab.xml EX-101.LAB 23834
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ocgn-20230821_pre.xml EX-101.PRE 12506
7 EXTRACTED XBRL INSTANCE DOCUMENT ocgn-20230821_htm.xml XML 2712
Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 231189756
SIC: 2836 Biological Products, (No Diagnostic Substances)